Sort   by:  
 Page size 
TranscriptomicsTranscription profiling of human dermal microvascular endothelial, fibroblast, and glioblastoma cells treated with mycophenolic acid
The effect of Mycophenolic acid on primary isolated human dermal microvascular endothelial (HDMVEC) and fibroblast cells as well as human glioblastoma brain tumor cell line (U87).
ORGANISM(S): Homo sapiens 
2008-06-25 | E-TABM-315 | biostudies-arrayexpress
TranscriptomicsEffect of Mycophenolic Acid on renal transplant recipients
Mycophenolic acid (MPA), an immunosuppressive drug widely used in kidney transplantation, has been suggested to have anti-fibrotic effects. To analyze at a genomic level these effects, we prospectively studied a group of stable kidney transplant recipients (n=35) on cyclosporine (CyA) and azathiopri...
ORGANISM(S): Homo sapiens 
2010-12-22 | E-GEOD-14630 | biostudies-arrayexpress
TranscriptomicsEffect of mycophenolic acid on MPC-1 murine podocytes
Mycophenolic Acid (MPA) is the active component of the immunosuppressant Mycophenolate Mofetil, a potent inhibitor of the inosine monophosphate dehydrogenase. Direct effects of MPA on podocytes remain largely unknown. In order to elucidate genes and pathways affected by the drug, cultured murine pod...
ORGANISM(S): Mus musculus 
2023-03-27 | E-MTAB-11702 | biostudies-arrayexpress
GenomicsEffect of mycophenolic acid on MPC-1 murine podocytes
Effect of mycophenolic acid on MPC-1 murine podocytes
PRJEB52911 | ENA
TranscriptomicsA broad array of anticancer activities of the immunosuppressive drug mycophenolic acid (MPA) is suggested by pathway analyses of gene expression and validated by proteomic and functional assays
Gene expression microarray was performed to assess the global changes coupled to targeted validation of proteomic profiling to reveal the broad anticancer activities of the immunosuppressive drug Mycophenolic acid (MPA) and elucidate the molecular mechanisms underlying these activities. We conducted...
ORGANISM(S): Homo sapiens 
2013-10-28 | E-GEOD-46671 | biostudies-arrayexpress
GenomicsMycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants
Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants
PRJNA1255141 | ENA
UnknownLC-MS/MS method for quantitation of mycophenolic acid, mycophenolic acid acyl-glucuronide, and 7-O-mycophenolic acid glucuronide in serum.
Not available
S-EPMC11322753 | biostudies-literature
GenomicsInter-individual variability in lymphocyte stimulation and transcriptomic response predicts mycophenolic acid sensitivity in healthy volunteers
Inter-individual variability in lymphocyte stimulation and transcriptomic response predicts mycophenolic acid sensitivity in healthy volunteers
PRJNA591800 | ENA
GenomicsA yeast-optimized single-cell transcriptomics platform elucidates how mycophenolic acid and guanine alter global mRNA levels
A yeast-optimized single-cell transcriptomics platform elucidates how mycophenolic acid and guanine alter global mRNA levels
PRJNA695455 | ENA
GenomicsA yeast-optimized single-cell transcriptomics platform elucidates how mycophenolic acid and guanine alter global mRNA levels
A yeast-optimized single-cell transcriptomics platform elucidates how mycophenolic acid and guanine alter global mRNA levels
PRJNA604244 | ENA
Sort   by:  
 Page size